sur Affluent Medical (isin : FR0013333077)
Affluent Medical to Attend German Fall Conference in Frankfurt in September 2024
Affluent Medical, a clinical-stage medical technology company from France, will participate in the German Fall Conference 2024 in Frankfurt am Main, from September 2nd to 3rd. This event is organized by Equity Forum and attracts financial analysts, investors, journalists, and capital market players.
On September 3, from 2:30 to 3:10 pm CEST, Christophe de Vregille, Chief Financial Officer of Affluent Medical, will present the company's latest achievements and future growth plans. He will also be available for 1-on-1 meetings with investors.
The company has made significant progress, notably with its medical device Artus, and ongoing clinical studies for Epygon and KaliosTM, which have drawn strategic partnerships, including an agreement with Edwards Lifesciences.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Affluent Medical